Join
Live feed
·
INSIDERFilingvia Quantisnow
Cerevel Therapeutics Holdings Inc. logo

Burgess Paul D. converted options into 23,847 shares, increasing direct ownership by 109% to 45,727 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CERE· Cerevel Therapeutics Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CERE (Cerevel Therapeutics Holdings Inc.) and more on Quantisnow.